A nurse is caring for a 7-year-old child who has a urinary tract infection (UTI)
​​

Exhibits

The nurse is planning care for the client.

For each of the following interventions, click to specify if the potential intervention is anticipated or contraindicated for the client.

A. Continuous monitoring of oxygen saturation is crucial in a vaso-occlusive crisis to detect any signs of hypoxia early, which could exacerbate the crisis and lead to more severe complications. This is important for assessing respiratory status, especially in patients with sickle cell disease who may be at risk for acute chest syndrome.

B. Oral intake should not be restricted during a vaso-occlusive crisis as hydration is important for maintaining adequate blood flow and preventing dehydration.

C. Hydroxyurea is used to reduce the frequency of painful crises in patients with sickle cell disease. It works by increasing the production of fetal hemoglobin, which can help prevent sickle cell crises.

D. Meperidine (Demerol) is an opioid analgesic commonly used to manage severe pain associated with sickle cell crises.

E. Vaccination is important in preventing infections, which can trigger or worsen a vaso-occlusive crisis in individuals with sickle cell disease. Ensuring the pneumococcal vaccine is current helps protect the adolescent from potential infections.

F. Placing the client on strict bed rest can increase the risk of thrombosis and impair circulation.

G. Folic acid supplementation is often recommended for patients with sickle cell disease to support red blood cell production and prevent folate deficiency, which can worsen anemia.

H. Cold compresses are not recommended as they can cause vasoconstriction, worsening the pain and sickling in vaso-occlusive crises. Warm compresses are generally preferred.

A. C-reactive protein (CRP) is an inflammatory marker that increases in response to inflammation, including in conditions like rheumatic fever.

B. An elevated antistreptolysin O (ASO) titer indicates a recent streptococcal infection, which is a key contributor to the development of rheumatic fever.

C. Partial thromboplastin time (PTT) measures blood clotting, which is not directly related to diagnosing rheumatic fever.

D. Blood urea nitrogen (BUN) assesses kidney function and is not specific to diagnosing rheumatic fever.

E. Erythrocyte sedimentation rate (ESR) is another inflammatory marker that increases with infection and inflammation, helping to support the diagnosis of rheumatic fever.